LBTB is proud to announce a strong increase of its turnover up to 50% for Q1 2024 with respect to Q1 2023.
We warmly thank our customers, partners and suppliers for their invaluable contribution to this achievement.


This outstanding result leads us to upgrade our offer and our service for the benefit of patients throughout Europe.
We aim to provide the highest quality of human tissues and enhance our innovative solutions such as the NerVFIX and the Visio Amtrix from Tissue Bank of France.


I feel very grateful to our team for their continued dedication and commitment.